{
  "catalogId": "acb702d0-0cb6-473d-8a4c-c1b5e965149d",
  "name": "VYXEOS LIPOSOMAL",
  "status": "draft",
  "category": "prescription",
  "registrationValidity": "valid",
  "registrationNumber": "169 36 36917 99",
  "treatmentDescriptions": "Vyxeos liposomal is indicated for the treatment of adults with newly diagnosed, therapy-related acute myeloid leukaemia (t-AML) or AML with myelodysplasia-related changes (AML-MRC).",
  "termsOfIssue": "Prescription required",
  "form": "powder for concentrate for solution for infusion",
  "route": "i.v",
  "site": "",
  "method": "",
  "administrationNotes": "",
  "ingredients": "CYTARABINE/VIAL, DAUNORUBICIN AS HCL/VIAL",
  "codes": {
    "atc5": {
      "system": "WHO ATC Classification",
      "code": "L01XY01",
      "name": "DAUNORUBICIN AND CYTARABINE"
    }
  },
  "contraindications": "",
  "sideEffect": "",
  "warnings": "תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת",
  "alternativeMedications": [],
  "packaging": [
    {
      "name": "VYXEOS 100MG / 44MG 1 VIAL",
      "manufacturer": {
        "name": "מדיסון",
        "countryOfOrigin": "IL"
      },
      "strength": {
        "value": 0,
        "unit": ""
      },
      "quantity": {
        "value": 1.0,
        "unit": "units"
      },
      "packagingDescription": "VIAL GLASS TYPE I",
      "shelfLife": "48",
      "storageConditions": "",
      "codes": {
        "moh": "9041",
        "yarpa": "43897"
      },
      "manufacturersAdministrationRecommendation": "",
      "pricing": {
        "currency": "ILS",
        "maxWholesalePrice": 21301.72625,
        "retailMargin": 10.0,
        "maxRetailPrice": 23431.89887,
        "maxPriceWithVAT": 27649.63944
      }
    }
  ],
  "metadata": {
    "version": "1.4",
    "lastUpdated": "2025-08-01T12:18:43.932240"
  }
}